OKYO Pharma announced the withdrawal of its proposed public offering of ordinary shares and its termination of Freedom Capital Markets as underwriter. The decision was made in response to changing market conditions.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on OKYO:
- OKYO Pharma Announces Closing of $4.0 Million Registered Direct Offering of Ordinary Shares
- OKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary Shares
- OKYO Pharma Limited Announces Withdrawal of Public Offering
- OKYO Pharma Announces Public Offering of Ordinary Shares
- OKYO Pharma files to sell ordinary stock, no amount given
